FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease

First Approval for Cats Under Conditional Approval Pathway SILVER SPRING, Md. , May 1, 2023 /PRNewswire/ –Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of nonregenerative anemia associated…